These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6125261)

  • 21. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
    Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
    Mimnaugh EG; Gram TE; Trush MA
    J Pharmacol Exp Ther; 1983 Sep; 226(3):806-16. PubMed ID: 6411900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.
    Tokarska-Schlattner M; Zaugg M; Zuppinger C; Wallimann T; Schlattner U
    J Mol Cell Cardiol; 2006 Sep; 41(3):389-405. PubMed ID: 16879835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of GM3 ganglioside on the adenyl and guanyl cyclase activity of cultured cells].
    Mandel P; Yusufi A; Helwig JJ; Rebel G
    C R Seances Soc Biol Fil; 1984; 178(6):641-6. PubMed ID: 6152547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of anthracyclines in the era of targeted therapy.
    Cortés-Funes H; Coronado C
    Cardiovasc Toxicol; 2007; 7(2):56-60. PubMed ID: 17652804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The cardiotoxicity of anthracyclines administered in childhood].
    Iarussi D; Indolfi P; Ratti G; Martiniello AR; Iacono A
    G Ital Cardiol; 1998 Dec; 28(12):1431-40. PubMed ID: 9887400
    [No Abstract]   [Full Text] [Related]  

  • 28. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
    Li W; Xu B; Xu J; Wu XL
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of guanyl nucleotides and hyperbaric oxygenation on the adenylate cyclase activity of the heart in rabbits with myocardial hypertrophy].
    Miroshnichenko VP; Demurov EA; Koloskov IuB; Zubovskaia AM
    Biull Eksp Biol Med; 1983 Feb; 95(2):17-9. PubMed ID: 6218842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanyl cyclase activity in Morris hepatomas. 7787, 7795, 7800 and 9618A-2.
    Northup SJ; Barthel JS; Brown HD; Chattopadhyay SK; Morris HP
    Mo Med; 1972 Dec; 69(12):934-7. PubMed ID: 4404883
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
    Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
    J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guanylate cyclase activity in fetal, neonatal and adult rat heart.
    Vesely DL; Chown J; Levey GS
    J Mol Cell Cardiol; 1976 Nov; 8(11):909-13. PubMed ID: 12374
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: a 10-year experience.
    Sallan SE; Clavell LA
    Semin Oncol; 1984 Dec; 11(4 Suppl 3):19-21. PubMed ID: 6594762
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical modification of steffimycin B.
    Wiley PF; Elrod DW; Harper DE
    J Antibiot (Tokyo); 1988 Mar; 41(3):343-51. PubMed ID: 3366692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of rubomycin on the cardiovascular system in chronic experiments on rabbits].
    Belova IP; Baumshteĭn VE
    Antibiotiki; 1970 Oct; 15(10):920-4. PubMed ID: 5487858
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of guanylate cyclase of various tissues and its in vitro modulation by effectors as a function of age of rats.
    Das R; Kanungo MS
    Exp Gerontol; 1981; 16(5):405-14. PubMed ID: 6119223
    [No Abstract]   [Full Text] [Related]  

  • 38. [Activation of guanyl cyclase during lipid peroxidation of biomembranes].
    Sobolev AS; Tertov VV; Rybalkin SD
    Biokhimiia; 1982 Aug; 47(8):1251-61. PubMed ID: 6127119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The circadian rhythm of guanylate cyclase and its interrelationship to rat liver chalone.
    Cannella NK; Vesely DL
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):207-17. PubMed ID: 6148775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors.
    Robert J
    Cardiovasc Toxicol; 2007; 7(2):135-9. PubMed ID: 17652818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.